ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
DAYBUE (trofinetide) launched in US - Neuren earns US$40m
Published: 18/04/23, 09:50am (AEST)•7 pages